Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Running, not enrolling

Conditions studied: Prostate Carcinoma

In brief

This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.

Key facts

Study ID

NCT04789018

Run by

Thomas Jefferson University

People needed

118

Starts

2020-01-21

Expected to finish

2026-06-24

Last updated by the study team

2025-10-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals must meet one of the following inclusion criteria in order to be eligible to participate in the study:
• Healthcare providers (medical oncologists, radiation oncologists, urologists, primary care providers, mid-level providers) who evaluate, manage, or treat men with prostate cancer or screen men for prostate cancer.
• Providers who perform prostate cancer genetic testing for men (genetic counselors or healthcare providers)
• Scientists and researchers
• Advocacy or patient stakeholder organization members

You may not qualify if…

• Non-medical providers

Where it is running

• Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.